ADDED
atii20251231_10k.htm FY 2025 --12-31 false 0002028516 1 5 0 0 0 0 0 0 0 6 1 0.5 1 1 0.5 1 0 0 0 10 1 0.5 1 1 0.5 1 750,000 3,000,000 0 0 0 0 0 0 false false false false We are a special purpose acquisition company with no business operations.
As of March 2, 2026, the registrant had 29,590,000 ordinary shares outstanding (inclusive of shares included in outstanding units).
Following the closing of the IPO, a total of $231,150,000 of the net proceeds from the sale of Units in the IPO (including the over-allotment option Units) and the private placement of the Private Placement Units, were placed in a trust account established for the benefit of the Company s public shareholders (the trust account ) with Odyssey Transfer and Trust Company acting as trustee.
We will have up to 21 months from the closing of the IPO to consummate an initial business combination.
We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of the initial business combination, including interest (net of funds withdrawn to pay our taxes), divided by the number of then issued and outstanding public shares, subject to certain limitations.
+7 more — sign up free →REMOVED
atii20241231_10k.htm 0002028516 Archimedes Tech SPAC Partners II Co.
false --12-31 FY 2024 false false false false false false 0.0001 1,000,000 0 0 0.0001 400,000,000 5,750,000 5,750,000 0.5 0.5 10 0 0 0.5 0.5 6 0 5,750,000 5 60 0.5 Excluded an aggregate of up to 750,000 ordinary shares that were subject to surrender and forfeiture depending on the extent to which the underwriters over-allotment option was exercised (see Note 5).
Included an aggregate of up to 750,000 ordinary shares that were subject to surrender and forfeiture depending on the extent to which the underwriters over-allotment option was exercised (see Note 5).
As of March 28, 2025, the registrant had 29,590,000 ordinary shares outstanding (inclusive of shares included in outstanding units).
We will have up to 21 months to consummate an initial business combination from the closing of the IPO.
+7 more — sign up free →